Sandbox Reserved 427
From Proteopedia
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
|
Contents |
Introduction
Insulin receptor ABOUT -tyrosine kinase (ligand-activated receptor kinase)
-expressed at cell surface as homodimers composed of alpha/beta monomers
-disulfide-linked ectodomain dimer - folded over conformation places ligands in correct relative positions (green scene)
-mediate activity by addition of phophate to tyrosines on specific proteins in cell
-found in organisms from cnidarians and insects to humans
-in humans essential for maintaining glucose levels
-also has role in growth and development (insulin growth factor II)
-signal through IGF2 to mediate embryonic growth (Kitamura et al)
FUNCTION -insulin receptor substrate 1 (IRS-1) binding leads to increase in high affinity glucose transporter (Glut4) molecules on the other membrane of cell (muscles, adipose)
-leads to increased glu uptake (Glut4 mediates transport of glu into cell)
DISEASE -decreased insulin resceptor signalling (aka insulin insensitivity)leads to diabetes mellitus type 2
- cells unable to take up glu => hyperglycemia (increased circulating glucose)
-aka non-insulin-dependent or adult onset diabetes
-beleived to be caused by obesity and genetic predisposition
-managed with dietary and lifestyle modifications
-mutations in both copies of the insulin receptor gene causes Donohue syndrome (leprechaunism)
-autosomal recessive; results in totally non-functional insulin receptor -results in distorted facial features, growth redardation and often death within a year
Overall Structure
-Ectodomain is dimer of 2 identical monomers (dimer green scene)
-Monomers composed of 6 domains (monomer green scene)
-Leucine-rich repeat domain (L1), secondary structures (green scene)
-Cystine-rich region (CR), secondary structures (green scene)
-Leucine-rich repeat domain (L2), secondary structures (green scene)
-Fibronectin Type III domain 1 (FnIII-1), secondary structures (green scene)
-Fibronectin Type III domain 2 (FnIII-2), secondary structures, insert domain (green scene)
-Fibronectin Type III domain 3 (FnIII-3), secondary structures (green scene)
Binding Interactions
Additional Features
Credits
Introduction - Rebecca Bishop
Overall Structure - Kathryn Liedell
Drug Binding Site - Ryan Deeney
Additional Features - Jeffrey Boerth
